ARQT - Arcutis Biotherapeutics surges 22% on Q1 beats
2024-05-15 11:45:04 ET
More on Arcutis Biotherapeutics
- Arcutis Biotherapeutics, Inc. (ARQT) Q1 2024 Earnings Call Transcript
- Arcutis Biotherapeutics: Betting Big On Zoryve
- Arcutis Biotherapeutics, Inc. (ARQT) Q4 2023 Earnings Call Transcript
- Arcutis announces pricing of $150 million public offering
- Arcutis licenses Japanese rights for Zoryve to Sato Pharmaceutical